• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型子宫内膜增生:接受子宫切除术患者隐匿性子宫内膜异型性和恶性肿瘤的危险因素。

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy.

作者信息

Hui Lee Shi, Chin Selina Hui Men, Goh Charissa, Hui Lin Xiao, Mathur Manisha, Kuei Timothy Lim Yong, Xian Felicia Chin Hui

机构信息

Department of Obstetrics & Gynecology, KK Women's and Children's Hospital, Singapore.

Department of Gynaecological Oncology, KK Women's and Children's Hospital, Singapore.

出版信息

Obstet Gynecol Sci. 2021 May;64(3):300-308. doi: 10.5468/ogs.20294. Epub 2021 Feb 25.

DOI:10.5468/ogs.20294
PMID:33631068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8138077/
Abstract

OBJECTIVE

To determine the risk factors for occult endometrial atypia and malignancy in patients diagnosed with non-atypical endometrial hyperplasia (NEH) on endometrial biopsy.

METHODS

All new cases of NEH diagnosed between April 2015 and March 2016 at KK Women's and Children's Hospital, who underwent hysterectomy as first-line treatment, were included in the study. Patients with a history of endometrial hyperplasia or malignancy were excluded from the study. Patient demographics (e.g., age, parity, body mass index [BMI]), medical history, and clinical presentation were obtained for analysis.

RESULTS

In total, 262 patients were diagnosed with NEH, of which 18.3% (n=48) underwent hysterectomy as first-line management. The average time to surgery was 77.0±35.7 days. All cases were diagnosed by dilation and curettage, and hysteroscopy. The mean age was 51 years, and the mean BMI was 26.9±5.8 kg/m2. Histology from the hysterectomy specimen showed 9 (18.8%) patients with atypical hyperplasia and 2 (4.2%) with grade 1, stage 1A endometrioid adenocarcinoma. Patients with higher grade final pathology had significantly lower median parity (1 vs. 2, P=0.039), higher mean BMI (30.1±6.5 vs. 25.9±5.3 kg/m2, P=0.033), and BMI ≥30 kg/m2 (54.5% vs. 13.5%, P=0.008, odds ratio 7.68), compared to patients whose final histology showed NEH or no residual hyperplasia.

CONCLUSION

Occult endometrial atypia and malignancy were found in 18.8% and 4.2% of patients with an initial diagnosis of NEH, respectively. High BMI and low parity were identified as significant risk factors for high-grade endometrial lesions in patients with NEH.

摘要

目的

确定经子宫内膜活检诊断为非典型子宫内膜增生(NEH)的患者发生隐匿性子宫内膜不典型增生及恶性病变的危险因素。

方法

纳入2015年4月至2016年3月期间在KK妇女儿童医院诊断为NEH且接受子宫切除术作为一线治疗的所有新病例。有子宫内膜增生或恶性肿瘤病史的患者被排除在研究之外。收集患者的人口统计学资料(如年龄、产次、体重指数[BMI])、病史和临床表现进行分析。

结果

共有262例患者被诊断为NEH,其中18.3%(n = 48)接受子宫切除术作为一线治疗。手术平均时间为77.0±35.7天。所有病例均通过刮宫术和宫腔镜检查确诊。平均年龄为51岁,平均BMI为26.9±5.8kg/m²。子宫切除标本的组织学检查显示,9例(18.8%)患者为非典型增生,2例(4.2%)为1级1A期子宫内膜样腺癌。与最终组织学显示为NEH或无残留增生的患者相比,最终病理分级较高的患者中位产次显著较低(1对2,P = 0.039),平均BMI较高(30.1±6.5对25.9±5.3kg/m²,P = 0.033),BMI≥30kg/m²的比例更高(54.5%对13.5%,P = 0.008,比值比7.68)。

结论

初诊为NEH的患者中,隐匿性子宫内膜不典型增生和恶性病变的发生率分别为18.8%和4.2%。高BMI和低产次被确定为NEH患者发生高级别子宫内膜病变的重要危险因素。

相似文献

1
Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy.非典型子宫内膜增生:接受子宫切除术患者隐匿性子宫内膜异型性和恶性肿瘤的危险因素。
Obstet Gynecol Sci. 2021 May;64(3):300-308. doi: 10.5468/ogs.20294. Epub 2021 Feb 25.
2
Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.对于患有非典型子宫内膜增生的高危女性,宫腔镜手术可能是子宫切除术的替代方案。
J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):68-73. doi: 10.1016/j.jmig.2006.08.007.
3
Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling.绝经后子宫内膜取样中非典型性子宫内膜增生妇女的长期结局。
Ultrasound Obstet Gynecol. 2020 Apr;55(4):546-551. doi: 10.1002/uog.20421. Epub 2020 Feb 28.
4
The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.子宫内膜增生患者细胞学异型性的预后及治疗意义。
Gynecol Oncol. 1994 Oct;55(1):66-71. doi: 10.1006/gyno.1994.1249.
5
Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.子宫内膜增生的诊断和管理:2012-2020 年英国国家审计对遵循国家指南的情况
PLoS Med. 2024 Feb 29;21(2):e1004346. doi: 10.1371/journal.pmed.1004346. eCollection 2024 Feb.
6
Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.绝经后出血且接受口服抗凝治疗的患者中,初次诊断为非典型子宫内膜增生后行子宫切除术时发生更高级别病变的风险。
Medicina (Kaunas). 2021 Sep 23;57(10):1003. doi: 10.3390/medicina57101003.
7
Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.刮宫标本组织病理学诊断为子宫内膜增生的患者,子宫切除标本中并发子宫内膜癌。
Ginekol Pol. 2015 Oct;86(10):753-8. doi: 10.17772/gp/57813.
8
Risk of occult atypical hyperplasia or cancer in women with nonatypical endometrial hyperplasia.非非典型子宫内膜增生女性发生隐匿性非典型增生或癌症的风险。
J Obstet Gynaecol Res. 2020 Dec;46(12):2505-2510. doi: 10.1111/jog.14474. Epub 2020 Sep 17.
9
Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia.对子宫内膜灌洗标本进行大规模平行测序,以检测非典型和典型子宫内膜增生中与癌症相关的突变。
Front Med (Lausanne). 2022 Dec 22;9:1090788. doi: 10.3389/fmed.2022.1090788. eCollection 2022.
10
Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.复杂非典型子宫内膜增生:未被识别的腺癌风险及术前刮宫扩张术的价值
Obstet Gynecol. 2009 Sep;114(3):523-529. doi: 10.1097/AOG.0b013e3181b190d5.

引用本文的文献

1
Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.绝经后出血且接受口服抗凝治疗的患者中,初次诊断为非典型子宫内膜增生后行子宫切除术时发生更高级别病变的风险。
Medicina (Kaunas). 2021 Sep 23;57(10):1003. doi: 10.3390/medicina57101003.

本文引用的文献

1
Risk of occult atypical hyperplasia or cancer in women with nonatypical endometrial hyperplasia.非非典型子宫内膜增生女性发生隐匿性非典型增生或癌症的风险。
J Obstet Gynaecol Res. 2020 Dec;46(12):2505-2510. doi: 10.1111/jog.14474. Epub 2020 Sep 17.
2
Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.复杂性非典型子宫内膜增生中隐匿性癌症的风险较大。
Arch Gynecol Obstet. 2019 Nov;300(5):1147-1154. doi: 10.1007/s00404-019-05299-2. Epub 2019 Sep 17.
3
Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding. Pipelle活检技术诊断异常子宫出血中子宫内膜疾病的疗效研究
J Midlife Health. 2019 Apr-Jun;10(2):75-80. doi: 10.4103/jmh.JMH_109_18.
4
Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling.绝经后子宫内膜取样中非典型性子宫内膜增生妇女的长期结局。
Ultrasound Obstet Gynecol. 2020 Apr;55(4):546-551. doi: 10.1002/uog.20421. Epub 2020 Feb 28.
5
Cancer of the corpus uteri.子宫体癌。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50. doi: 10.1002/ijgo.12612.
6
Complex non atypical hyperplasia and the subsequent risk of carcinoma, atypia and hysterectomy during the following 9-14 years.复杂性非典型增生以及随后9至14年间发生癌变、出现异型性和进行子宫切除术的风险。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:171-175. doi: 10.1016/j.ejogrb.2018.01.026. Epub 2018 Feb 5.
7
Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.刮宫标本组织病理学诊断为子宫内膜增生的患者,子宫切除标本中并发子宫内膜癌。
Ginekol Pol. 2015 Oct;86(10):753-8. doi: 10.17772/gp/57813.
8
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.左炔诺孕酮宫内缓释系统或口服孕激素治疗后子宫内膜增生的复发风险。
BJOG. 2016 Aug;123(9):1512-9. doi: 10.1111/1471-0528.13763. Epub 2015 Dec 2.
9
Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia.术前诊断为子宫内膜增生的患者中并存子宫内膜癌的患病率
J Clin Diagn Res. 2015 Oct;9(10):QC10-4. doi: 10.7860/JCDR/2015/12484.6618. Epub 2015 Oct 1.
10
New WHO Classification of Endometrial Hyperplasias.世界卫生组织子宫内膜增生的新分类
Geburtshilfe Frauenheilkd. 2015 Feb;75(2):135-136. doi: 10.1055/s-0034-1396256.